Blog Elements

Half Sized Blog Element (Single Author Style)

Half Sized Blog Element (Multi Author Style)

Local Recurrences of Giant Cell Tumor of Bones after Extended Surgical Curettage – A Retrospective Cohort Study

January 10, 2020

Original Article | Volume 6 | Issue 1 | JBST January-April 2020 | Page 9-12 | DOI: 10.13107/jbst.2020.v06i01.007 Author: Dominic K Puthur [1], Dijoe Davis [1], N Sanjay [1] 1. Department of Orthopaedics, Amala Institute of Medical Sciences, Thrissur, Kerala, India. Address of Correspondence Dr. Dijoe Davis, Department of Orthopaedics, Amala Institute of Medical Sciences, […]

Factors Predicting Massive Blood Loss in Patients Undergoing Pelvic Resection: A Tertiary Referral Center Experience from North India

January 10, 2020

Original Article | Volume 6 | Issue 1 | JBST January-April 2020 | Page 5-8 | DOI: 10.13107/jbst.2020.v06i01.006 Author: Devansh Goyal [1], Venkatesan Sampath Kumar [1], Roshan Banjara [1], Abdul Majeed [1], R Namith [1], Shah Alam Khan [1] 1. Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi, India. Address of Correspondence […]

Local Recurrences of Giant Cell Tumor of Bones after Extended Surgical Curettage – A Retrospective Cohort Study

January 10, 2020

Factors Predicting Massive Blood Loss in Patients Undergoing Pelvic Resection: A Tertiary Referral Center Experience from North India

January 10, 2020

Full Sized Blog Element (Big Preview Pic)

Local Recurrences of Giant Cell Tumor of Bones after Extended Surgical Curettage – A Retrospective Cohort Study

January 10, 2020

Author: Dominic K Puthur [1], Dijoe Davis [1], N Sanjay [1]

1. Department of Orthopaedics, Amala Institute of Medical Sciences, Thrissur, Kerala, India.

Address of Correspondence
Dr. Dijoe Davis,
Department of Orthopaedics, Amala Institute of Medical Sciences,
Cloud Nine, Kollannur Villas, Jasmin Road, Near Water Tank Street
Nehrunagar, Kuriachira P.O, Thrissur – 680 006, Kerala, India.
E-mail: dr.dijoe@gmail.com

Abstract

Introduction: Giant cell tumor of bone (GCTB) is a locally aggressive tumor well known for recurrence after surgical treatment. Local recurrence rate ranged from 10 to 25%. The objectives of this study are to find out the incidence of recurrence in GCT after extended surgical curettage, factors affecting recurrence, and also to find the best modality of treatment available for the recurred GCT.
Materials and Methods: It was a retrospective cohort study of 225 patients diagnosed and treated by extended surgical curettage in the Orthopaedic Department of a Tertiary Care Hospital in South India, between January 2003 and December 2017. Patients were followed up clinically and radiologically for diagnosis of recurrence. Factors affecting the recurrence were analyzed. These recurrent cases were further followed up. IBM SPSS v23 was used for data analysis such as age, gender, site of lesion and side, and material used to fill the defect after curettage. Descriptive statistics was elaborated in the form of means and standard deviations for continuous variables and frequencies and percentages for categorical variables. Fisher’s exact test is used for comparison.
Results: Recurrence was found in 27 patients of 225 cases of GCTB treated by extended surgical curettage. These include 9 of 135 cases initially treated by extended curettage and bone cement and 18 of 88 cases initially treated by curettage and bone graft. Recurrence was found to be more common in males than females.
Conclusions: Local recurrence is significantly lower in patients treated by cementation following extended surgical curettage than bone graft which makes bone cement as a better filling material with regard to recurrence.
Keywords: Giant cell tumor, Curettage, Bone cement, Bone graft, South India.

References

1. Fletcher CD. Who Classification of Tumours of Soft Tissue and Bone. Geneva: World Health Organization; 2013.
2. Puri A, Agarwal M. Treatment of giant cell tumor of bone: Current concepts. Indian J Orthop 2007;41:101-8.
3. Sobti A, Agrawal P, Agarwala S, Agarwal M. Giant cell tumor of bone-an overview. Arch Bone Jt Surg 2016;4:2-9.
4. Rao PT. Management of giant cell tumor of bone. Kini memorial oration. Indian J Orthop 1993;27:96-100.
5. Huvos AG. Bone Tumors: Diagnosis, Treatment and Prognosis. 2nd ed. Philadelphia, PA: WB Saunders Co.; 1991. p. 429.
6. Reddy CR, Rao PS, Rajakumari K. Giant cell tumour of bone in South India. J Bone Joint Surg 1974;56:617-9, 106-114.
7. Ghert MA, Rizzo M, Harrelson JM, Scully SP. Giant-cell tumor of the appendicular skeleton. Clin Orthop Relat Res 2002;400:201-10.
8. Saiz P, Virkus W, Piasecki P, Templeton A, Shott S, Gitelis S. Results of giant cell tumor of bone treated with intralesional excision. Clin Orthop Relat Res 2004;424:221-6.
9. Cavanna L, Biasini C, Monfredo M, Maniscalco P, Mori M. Giant cell tumor of bone. Oncologist 2014;19:1207.
10. Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am 2006;37:35-51.
11. Nelson DA, Barker ME, Hamlin BH. Thermal effects of acrylic cementation at bone tumour sites. Int J Hyperthermia 1997;13:287-306.
12. Nicholson NC, Ramp WK, Kneisl JS, Kaysinger KK. Hydrogen peroxide inhibits giant cell tumor and osteoblast metabolism in vitro. Clin Orthop Relat Res 1998;347:250-60.
13. Quint U, Müller RT, Müller G. Characteristics of phenol. Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma. Arch Orthop Trauma Surg 1998;117:43-6.
14. Balke M, Ahrens H, Streitbuerger A, Koehler G, Winkelmann W, Gosheger G, et al. Treatment options for recurrent giant cell tumors of bone. J Cancer Res Clin Oncol 2009;135:149-58.
15. Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Recurrent giant cell tumor of long bones: Analysis of surgical management. Clin Orthop Relat Res 2011;469:1181-7.
16. Puthoor DK, Puthezhath K. Management of giant cell tumor of bone: Computerized tomography based selection strategy and approaching the lesion through the site of cortical break. Orthop Surg 2012;4:76-82.
17. Puthoor D, Iype W. Giant cell tumor: Curettage and bone grafting. Indian J Orthop 2007;41:121-3.
18. Dominic K, Dijoe D, Aravind R. Extended curettage and reconstruction with proximal fibula for treating giant cell tumor of lateral femoral condyle: A prospective study. Arch Clin Exp Surg 2017;6:1.
19. Puthoor DK, Davis D, Francis L. The incidence and distribution of pathological fractures in giant cell tumour of bone-a retrospective study. Kerala J Orthop 2018;31920:27-31.
20. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am 1987;69:106-14.
21. Lausten GS, Jensen PK, Schiødt T, Lund B. Local recurrences in giant cell tumour of bone. Long-term follow up of 31 cases. Int Orthop 1996;20:172-6.
22. Vult von Steyern F, Bauer HC, Trovik C, Kivioja A, Bergh P, Holmberg Jörgensen P, et al. Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian sarcoma group
study. J Bone Joint Surg Br 2006;88:531-5.
23. Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, et al. Giant cell tumor of long bone: A Canadian sarcoma group study. Clin Orthop Relat Res 2002;397:248-58.
24. Nahal A, Ajlan A, Alcindor T, Turcotte R. Dedifferentiated giant cell tumour of bone in the form of low-grade fibroblastic osteogenic sarcoma: Case report of a unique presentation with follow-up. Curr Oncol
2010;17:71-6.
25. Bertoni F, Bacchini P, Staals EL. Malignancy in giant cell tumor of bone. Cancer 2003;97:2520-9.
26. Mendenhall WM, Zlotecki RA, Scarborough MT, Gibbs CP, Mendenhall NP. Giant cell tumor of bone. Am J Clin Oncol 2006;29:96-9.
27. Tubbs WS, Brown LR, Beabout JW, Rock MG, Unni KK. Benign giantcell tumor of bone with pulmonary metastases: Clinical findings and radiologic appearance of metastases in 13 cases. AJR Am J Roentgenol
1992;158:331-4.
28. Dahlin DC. Caldwell lecture. Giant cell tumor of bone: Highlights of 407 cases. AJR Am J Roentgenol 1985;144:955-60.

How to Cite this article: Puthur D K, Davis D, Sanjay N | Local Recurrences of Giant Cell Tumor of Bones After Extended Surgical Curettage– A Retrospective Cohort Study | Journal of Bone and Soft Tissue Tumors | Jan-Apr 2020; 6(1): 9-12.

[Full Text HTML] [Full Text PDF] [XML]

Factors Predicting Massive Blood Loss in Patients Undergoing Pelvic Resection: A Tertiary Referral Center Experience from North India

January 10, 2020

Author: Devansh Goyal [1], Venkatesan Sampath Kumar [1], Roshan Banjara [1], Abdul Majeed [1],
R Namith [1], Shah Alam Khan [1]

1. Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi, India.

Address of Correspondence
Dr. Venkatesan Sampath Kumar,
Department of Orthopaedics, All India Institute of Medical
Sciences, Ansari Nagar, New Delhi – 110 029, India.
E-mail: venkatortho4@gmail.com

Abstract

Background: Pelvic resections are challenging procedures with significant risk of morbidity, especially massive blood loss. Risk factors for massive blood loss are understudied due to the rarity of such procedures.
Materials and Methods: A cross-sectional study was performed on pelvic resections performed between January 2018 and October 2019. Intraoperative and perioperative data were collected from prospectively collected database and hospital medical records. Patients were divided into two groups– Group 1 with intraoperative blood loss <2 L and Group 2 with blood loss 2 L or more. Demographic data, tumor characteristics, surgical procedure, and perioperative outcomes were studied between the two groups. Patients in whom only soft-tissue resections were performed and those who did not have complete data were excluded from the study.
Results: Of the 27 patients identified, 2 had soft-tissue recurrence resections only and 4 had incomplete data and were excluded from the study. Of the remaining 21 patients, 8 were classified into Group 1 and 13 into Group 2. On studying the various characteristics, tumor type, tumor volume, type of pelvic resection, and duration of procedure were significantly different between the two groups. Although wound complications, 30-day mortality, and read missions were higher in Group 2, this difference was not statistically significant.
Conclusion: Massive blood loss was more common in chondrosarcoma patients, with tumor volume more than 300 cc and the duration of procedure more than 4 h with resection involving the acetabulum and pubis (Type I/II/III and Type I/II/III/IV).
Keywords: Blood loss, Pelvic resections, Perioperative morbidity, Pelvic tumor surgery, Tumor volume.

References

1. AbuduA, GrimerRJ, CannonSR, CarterSR, SneathRS. Reconstruction of the hemipelvis after the excision of malignant tumours. Complications and functional outcome of prostheses.J Bone Joint Surg Br1997;79:773-9.
2. WurtzLD, PeabodyTD, SimonMA. Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis.J Bone Joint Surg Am1999;81:317- 25.
3. CarterSR, EastwoodDM, GrimerRJ, SneathRS. Hindquarter amputation for tumours of the musculoskeletal system.J Bone Joint Surg Br1990;72:490-3.
4. EnnekingWF, DunhamWK. Resection and reconstruction for primary neoplasms involving the innominate bone.J Bone Joint Surg Am1978;60:731-46.
5. KawaiA, KadotaH, YamaguchiU, MorimotoY, OzakiT, BeppuY. Blood loss and transfusion associated with musculoskeletal tumor surgery.J Surg Oncol2005;92:52-8.
6. SatcherRL Jr., O’DonnellRJ, JohnstonJO. Reconstruction of the pelvis after resection of tumors about the acetabulum.Clin OrthopRelat Res2003;409:209-17.
7. GutierrezG, ReinesHD, Wulf-GutierrezME. Clinical review: Hemorrhagic shock.Crit Care2004;8:373-81.
8. EnnekingWF, SpanierSS, GoodmanMA. A system for the surgical staging of musculoskeletal sarcoma.Clin OrthopRelat Res1980;153:106- 20.
9. AliAlgadiem E, AleisaAA, AlsubaieHI, BuhlaiqahNR, AlgadeebJB, AlsneiniHA. Blood loss estimation using gauze visual analogue.Trauma Mon2016;21:e34131.
10. GöbelV, JürgensH, EtspülerG, KemperdickH, JungblutRM, StienenU, et al. Prognostic significance of tumor volume in localized Ewing’s sarcoma o f b o n e i n c h i l d r e n a n d a d o l e s c e n t s . J C a n c e r R e s C l i n
Oncol1987;113:187-91.
11. RiedelRF, LarrierN, DoddL, KirschD, MartinezS, BrigmanBE. The clinical management of chondrosarcoma.Curr Treat Options Oncol2009;10:94-106.
12. TangX, GuoW, YangR, TangS, JiT. Evaluation of blood loss during limb salvage surgery for pelvic tumours.Int Orthop2009;33:751-6.
13. AljassirF, BeadelGP, TurcotteRE, GriffinAM, BellRS, WunderJS, et al. Outcome after pelvic sarcoma resection reconstructed with saddle prosthesis.Clin OrthopRelat Res2005;438:36-41.
14. BeneveniaJ, CyranFP, BiermannJS, PattersonFR, LeesonMC. Treatment of advanced metastatic lesions of the acetabulum using the saddle prosthesis.Clin OrthopRelat Res2004;426:23-31.
15. VenaVE, HsuJ, RosierRN, O’KeefeRJ. Pelvic reconstruction for severe periacetabular metastatic disease.Clin OrthopRelat Res1999;362:171-80.

How to Cite this article: Goyal D, Kumar VS, Banjara R, Majeed A, Namith R, Khan SA | Factors Predicting Massive Blood Loss in Patients Undergoing Pelvic Resection: A Tertiary Referral Center Experience from North India | Journal of Bone and Soft Tissue Tumors | January-April 2020; 6(1): 5-8.

Half Sized Blog Element (Single Author Style)

Half Sized Blog Element (Multi Author Style)

Local Recurrences of Giant Cell Tumor of Bones after Extended Surgical Curettage – A Retrospective Cohort Study

Like this:

Factors Predicting Massive Blood Loss in Patients Undergoing Pelvic Resection: A Tertiary Referral Center Experience from North India

Like this:

Local Recurrences of Giant Cell Tumor of Bones after Extended Surgical Curettage – A Retrospective Cohort Study

Like this:

Factors Predicting Massive Blood Loss in Patients Undergoing Pelvic Resection: A Tertiary Referral Center Experience from North India

Like this:

Full Sized Blog Element (Big Preview Pic)

Local Recurrences of Giant Cell Tumor of Bones after Extended Surgical Curettage – A Retrospective Cohort Study

[Full Text HTML] [Full Text PDF] [XML]

Like this:

Factors Predicting Massive Blood Loss in Patients Undergoing Pelvic Resection: A Tertiary Referral Center Experience from North India

[Full Text HTML] [Full Text PDF] [XML]

Like this:

Like this:

Journal of Bone and Soft Tissue Tumors (JBST) Editorial Office

Important Information

Journal of Bone and Soft Tissue Tumors (JBST) License

Half Sized Blog Element (Single Author Style)

Half Sized Blog Element (Multi Author Style)

Like this:

Like this:

Like this:

Like this:

Full Sized Blog Element (Big Preview Pic)

[Full Text HTML] [Full Text PDF] [XML]

Like this:

[Full Text HTML] [Full Text PDF] [XML]

Like this:

Share this:

Like this:

Journal of Bone and Soft Tissue Tumors (JBST) Editorial Office

Important Information

Journal of Bone and Soft Tissue Tumors (JBST) License